Non-HDL cholesterol is a critical target for cardiovascular disease prevention in patients with type 2 diabetes, with a recommended goal of < 130 mg/dl.
Answers are grounded in this paper and cite their sources.
May inform lipid assessment in diabetes beyond LDL; leaves open randomized trials on targeting non-HDL.
IN BRIEF Patients with type 2 diabetes have high rates of cardiovascular disease(CVD), much of which may be preventable with appropriate treatment of lipid abnormalities. Diabetic dyslipidemia most commonly manifests as elevated triglycerides and low levels of HDL cholesterol, with a predominance of small,dense LDL particles amid relatively normal LDL cholesterol levels. In diabetic patients, non-HDL cholesterol may be a stronger predictor of CVD than LDL cholesterol or triglycerides because it correlates highly with atherogenic lipoproteins. Target goals for LDL and non-HDL cholesterol in patients with diabetes are < 100 and < 130 mg/dl, respectively. Failure to consider the importance of non-HDL cholesterol in type 2 diabetes may result in undertreatment of patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Anne L. Peters (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: